Vise Technologies Inc. Acquires New Position in Corteva, Inc. $CTVA

Vise Technologies Inc. acquired a new stake in shares of Corteva, Inc. (NYSE:CTVA) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 22,135 shares of the company’s stock, valued at approximately $1,875,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. E Fund Management Co. Ltd. acquired a new position in shares of Corteva during the 2nd quarter worth $210,000. Bell & Brown Wealth Advisors LLC acquired a new stake in Corteva in the second quarter valued at about $1,231,000. Johnson Financial Group Inc. acquired a new stake in Corteva in the second quarter valued at about $63,000. Tocqueville Asset Management L.P. bought a new position in Corteva in the second quarter valued at about $843,000. Finally, NewEdge Wealth LLC bought a new position in Corteva in the second quarter valued at about $1,253,000. 81.54% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms have recently commented on CTVA. Barclays increased their target price on shares of Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a report on Thursday, June 11th. Oppenheimer lifted their price target on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, July 23rd. JPMorgan Chase & Co. upped their price objective on shares of Corteva from $77.00 to $83.00 and gave the stock a “neutral” rating in a research report on Monday, August 3rd. CICC Research increased their price objective on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Finally, Mizuho raised their target price on shares of Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research report on Tuesday, July 14th. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $91.50.

Corteva Price Performance

Corteva stock opened at $81.84 on Friday. The stock has a 50-day moving average price of $82.13 and a two-hundred day moving average price of $80.21. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97. The company has a market capitalization of $54.60 billion, a PE ratio of 54.20, a P/E/G ratio of 2.44 and a beta of 0.57. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same period in the previous year, the business posted $2.20 earnings per share. The business’s quarterly revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s payout ratio is presently 47.68%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.